Synergy CHC Corp. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Synergy CHC Corp. (SNYR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.67 million shares for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-06-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2020-06-29
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-03-31 was 5.67M shares, a 20.93% decline year-over-year.
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 7.17M shares, a 25.86% decline year-over-year.
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-03-31 was 9.67M shares, a 32.42% increase year-over-year.
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-09-30 was 7.30M shares, a 30.79% decline year-over-year.
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 6.17M shares, a 13.95% decline from fiscal 2018.
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 7.17M shares, a 25.86% decline from fiscal 2017.
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 9.67M shares, a 32.42% increase from fiscal 2016.
- Synergy CHC Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 7.30M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2020-03-31 | 5.67M shares 10-Q · filed 2020-06-29 | ||||
| 2019-12-31 | 6.17M shares 10-K · filed 2020-04-29 | ||||
| 2019-09-30 | 6.17M shares 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | 6.17M shares 10-Q · filed 2019-08-13 | ||||
| 2019-03-31 | 7.17M shares 10-Q · filed 2020-06-29 | ||||
| 2018-12-31 | 7.17M shares 10-K · filed 2020-04-29 | ||||
| 2018-09-30 | 8.17M shares 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | 9.67M shares 10-Q · filed 2019-08-13 | ||||
| 2018-03-31 | 9.67M shares 10-Q · filed 2019-05-03 | ||||
| 2017-12-31 | 9.67M shares 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | 7.30M shares 10-Q · filed 2017-11-13 | 7.30M shares 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | 7.30M shares 10-Q · filed 2017-08-14 | 7.30M shares 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | 7.30M shares 10-Q · filed 2018-05-15 | ||||
| 2016-12-31 | 7.30M shares 10-K · filed 2018-04-02 | 3.00M shares 10-Q · filed 2017-05-01 | |||
| 2016-09-30 | 10.55M shares 10-Q · filed 2017-11-13 | 10.55M shares 10-Q · filed 2017-11-13 | |||
| 2016-06-30 | 16.10M shares 10-Q · filed 2017-08-14 | 6.00M shares 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |